The invention relates to methods of treating insulin resistance in mammals, preferably in humans, which methods comprise administering to a mammal in need thereof an effective amounts of succinic acid or a pharmaceutically acceptable salts thereof.

A invenção relaciona-se aos métodos de tratar a resistência de insulin nos mamíferos, preferivelmente nos seres humanos, que os métodos compreendem a administração a um mamífero na necessidade disso de umas quantidades eficazes de ácido succinic ou sais pharmaceutically aceitáveis disso.

 
Web www.patentalert.com

< Inhibitors of formation of advanced glycation endproducts (AGES)

< Carboxylic acid derivatives and drugs containing the same as the active ingredient

> Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

> Pharmaceuticals for neurogenic pain

~ 00061